Introduction {#S1}
============

Pioneer colonization of intestinal microbiota has a major effect on driving the maturation and composition course of microbial communities over time ([@B17]; [@B30]; [@B34]). Later, the cross-talk between microbiota composition and immune cells has been highly associated with the establishment of immune competence ([@B7]; [@B6]; [@B32]; [@B9]). Germ-free mouse models have been essential to reveal a strong influence of intestinal microbial communities on the proper immune function. The lack of intestinal microbiota in these mice caused extensive deficits in the development of the gut-associated lymphoid tissues, abnormal production of immune cells, and other immunological deficiencies ([@B31]). In this context, a recent study with broilers has shown that the use of antibiotics during early life perturbed microbiota colonization, subsequently triggering an alteration in systemic immune programming ([@B32]). Nevertheless, the specific microbial populations involved in immune-modulatory functions are beginning to be deciphered with the advancement of metagenomic analyses.

It has been reported by [@B18] that the avian neonatal phase is an important window of opportunity to manipulate the intestinal microbiome toward beneficial bacterial growth. In fact, our previous studies showed that early exposure of embryos to lactic acid bacteria or *Enterobacteriaceae* strains resulted in different microbiome profiles at day of hatch and 10 days of age, suggesting that neonatal exposure to beneficial bacteria may be critical for influencing gastrointestinal tract (GIT) populations throughout the maturation of the poultry microbiota ([@B34]). However, whether this pioneer intestinal microbiome modulation can affect the host immunological functions remain unclear.

In this study, the influence of early intestinal bacterial colonization on the inflammatory and immune response of young broilers was investigated. For this purpose, two non-pathogenic *Enterobacteriacea*e isolates and a lactic acid bacteria-based probiotics were introduced *in ovo*, and mass spectrometry-based proteome analysis was performed on ileum tissue. To test our hypothesis, we focused on intestinal inflammatory and immune-related proteins, screened the biological functions predicted by Ingenuity Pathway Analysis (IPA), and linked inflammation biomarkers to intestinal microbial signatures established in the ileal microbiome of 10-day-old broiler chickens.

Materials and Methods {#S2}
=====================

Experimental Design {#S2.SS1}
-------------------

A total of 400 eggs from commercial Ross 708 broiler breeder flocks were obtained from a local hatchery. Per standard operating procedures, the eggs were sanitized before storage and incubation. All eggs were incubated under standard conditions at the Ohio Agricultural Research and Development Center's poultry research farm. Once eggs were confirmed fertile, at embryonic day 18, the air-cell end of each egg was treated with iodine (povidone--iodine 10% topical solution, Drug Mart, Medina, OH, United States) before a small hole was punched into the shell with an inoculation needle. *In ovo* inoculations contained one of the following: 0.2 ml of 0.9% sterile saline (S), which served as the control group, or approximately 10^2^ cells of *Citrobacter freundii* (CF), *Citrobacter* spp. (C2), or lactic acid bacteria mixture (L) administered into the amnion ([Figure 1](#F1){ref-type="fig"}). After inoculation, up to 30 eggs were allocated by treatments into three separate benchtop hatchers (Hova-Bator model 1602N, Savannah, GA, United States) for a total of 12 hatchers. All hatchers were disinfected with 10% bleach before use. Strains CF and C2 were selected from our previous study as non-pathogenic bacteria from the gut of healthy birds ([@B2]), and the homology of strains was confirmed by next-generation sequencing. The L culture was composed of a mixed inoculum of *Lactobacillus salivarius* and *Pediococcus* sp. Bacterial inoculations were prepared as described by [@B34]. Preliminary experimental observations concluded that the inclusion of isolates at ∼10^2^ CFU did not affect hatchability compared to the S control treatment (data not published). All experimental procedures were approved by the Ohio State University's Institutional Animal Care and Use Committee.

![Schematic overview of experimental design and gastrointestinal (GIT) tissue collection for proteome analyses. (**A**) Four hundred eggs were incubated under standard conditions in one single-stage egg incubator until embryonic day 18. (**B**) *In ovo* inoculations contained one of the following: 0.2 ml of 0.9% sterile saline (S), which served as the control group, or ∼10^2^ cells of *Citrobacter freundii* (CF), *Citrobacter* spp. (C2), or a lactic acid bacteria mixture (L) was administered into the amnion. (**C**) After inoculation, up to 30 eggs were allocated by treatments into three separate benchtop hatchers per treatment. (**D**) Ten days posthatch, chicks were selected for ileum sample collection (pooled samples of two birds per treatment) to perform proteome analyses.](fphys-11-00020-g001){#F1}

Sample Collection {#S2.SS2}
-----------------

Immediately posthatch, chicks were comingled on a treatment basis, and 128 chicks were placed into treatment-separated brooder battery cages with *ad libitum* access to a standard corn--soy diet and water ([@B27]). At 10 days posthatch, 12 chicks per treatment were randomly selected for ileal proteome analysis, however, only nine birds were sampled from CF. Chicks were euthanized via cervical dislocation, and the region proximal to the ileocecal junction and distal to Meckel's diverticulum, designated as lower ileum, was aseptically collected *post mortem* ([Figure 1](#F1){ref-type="fig"}). Ileum tissue was placed into 1.5-ml tubes, flash frozen in liquid nitrogen at the time of collection, and stored at −80°C until further use.

Once thawed, 0.1 g of ileal tissue from each sample was individually placed in 5 ml of buffer (8 M urea/2 M thiourea, 2 mM dithiothreitol, 50 mM Tris, 5% sodium dodecyl sulfate). The extraction protocol was a modified version previously described by [@B14] and [@B21]. In brief, samples were homogenized for 5 s (PRO250 Homogenizer, Pro Scientific, Oxford, CT, United States), then 500 μl of homogenate was added to 2-ml tubes containing 0.1 g stainless steel beads (SSB14B Next Advance, Averill Park, NY, United States). Samples were homogenized for a total of 3 min in 30-second intervals (MiniBeadbeater-16, Model 607, BioSpec Products, Bartlesville, OK, United States) and centrifuged at 4°C at 14,000 rpm (21,952 × *g*) for 20 min. The supernatant was collected, aliquoted, and placed into −80°C until further use.

To ensure proper extraction, concentration of total protein was quantified with the Bradford assay (Bradford reagent, VWR, Suwanee, GA, United States) and a standard bovine serum albumin curve (VWR, Suwanee, GA, United States) on a Synergy HTX multimode plate reader (BioTek U.S., Winooski, VT, United States). Samples were mixed to create pooled samples of two birds per treatment (*n* = 6 samples for L and C2; *n* = 5 samples CF; [Figure 1](#F1){ref-type="fig"}) and sent to the Ohio State University Proteomics Core lab for in-solution digestion and mass spectrometry.

Proteomics Analyses {#S2.SS3}
-------------------

Samples were precipitated with trichloroacetic acid and then resuspended in 50 mM ammonium bicarbonate. A total of 5 ml of dithiothreitol (5 μg/μl in 50 mM ammonium bicarbonate) was added, and the samples were incubated at 56°C for 15 min. After incubation, 5 μl of iodoacetamide (15 mg/ml in 50 mM ammonium bicarbonate) was added, and the samples were kept in the dark at room temperature for 30 min. Sequencing grade-modified trypsin (Promega; Madison, WI, United States) prepared in 50 mM ammonium bicarbonate was added to each sample at an estimated 1:20/1:100 enzyme/substrate ratio and incubated at 37°C overnight. The reaction was quenched the following day by adding acetic acid for acidification. Once samples were quenched, the peptide concentration was measured by Nanodrop (Thermo Scientific Nanodrop 2000; Waltham, MA, United States).

Capillary-liquid chromatography-nanospray tandem mass spectrometry (capillary-LC/MS/MS) of global protein identification was performed on a Thermo Fisher Fusion mass spectrometer (Thermo Scientific, Waltham, MA, United States). Samples were separated on a Thermo Nano C18 column (UltiMate^TM^ 3000 HPLC system, Thermo Scientific; Waltham, MA, United States). The MS/MS data sequences were scanned and based on the preview mode data-dependent TopSpeed^TM^ method with collision-induced dissociation and electron-transfer dissociation as fragmentation methods. The raw data were searched on Sequest via Proteome Discoverer (Proteome Discoverer^TM^ software, Thermo Scientific, Waltham, MA, United States). The data were searched against the most recent Uniprot *Gallus gallus* database for the identification of proteins. Only proteins with \<0.05 false discovery rate were reported. Proteins with a Mascot score of 50 or higher with a minimum of two unique peptides from one protein having a −b or −y ion sequence tag of five residues or better were accepted. Any modifications or low-score peptide/protein identifications were manually checked for validation.

Biological Interpretation {#S2.SS4}
-------------------------

Label-free quantitation was performed using the spectral count approach, in which the relative protein quantitation is measured by comparing the number of MS/MS spectra identified from the same protein in each of the multiple LC/MS/MS datasets. Comparisons between *in ovo* bacterial treatments and S control group were performed in Scaffold (Scaffold 4.8.4, Proteome Software, Portland, OR, United States). Student's *t* test (*p* \< 0.05) was performed to identify significance across the fold-change values. Differentially expressed proteins (DEPs) at the level of *p* ≤ 0.10 were uploaded into IPA system^[1](#footnote1){ref-type="fn"}^ to retrieve further inflammatory and immune information in terms of gene ontology, upstream regulators, and causal networks. The IPA functionalities for differentially expressed genes in chicken are based primarily on mammalian biological mechanisms ([@B20]). The statistical measure *Z* score was displayed to make predictions about potential activation (*Z* score ≥ 2.00) or inhibition (*Z* score [\<]{.ul} −2.00) of regulators using the information of the protein regulation direction. Qualified predictions were also made for high (*Z* score ≥ \| 1.90\| or more) medium (*Z* score = \| 1.70--1.90\|) or low (*Z* score = \| 1.50--1.70\|), respectively ([@B21]). Casual networks were performed to show mechanistic hypotheses to explain the expression changes observed in the datasets based on cause--effect relationships reported in the literature ([@B22]). The *p* value of the overlap, which measures any significant statistical overlap between the samples in the dataset and the genes that are regulated by the corresponding transcriptional regulator, was also determined and recorded. Fisher's exact test calculated the value at a significance of *p* \< 0.05.

Correlation Analyses {#S2.SS5}
--------------------

To further identify the specific bacterial groups that primarily accounted for the differences observed in the expression of inflammation-related proteins in the ileum of broilers, the microbiome data of same samples were added into the analysis, from BioProject ID [PRJNA552855](PRJNA552855), previously published by [@B30]. The most dominant genus-level operational taxonomic units detected in the four treatments were identified ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}). Based on the inflammatory annotation generated by the IPA system, the DEPs involved in the inflammation signaling also were determined. Given the considerable number of variables, only overexpressed proteins or those with at least one upregulated DEP within each treatment dataset were selected. Owing to the unlikelihood of perfectly linear relationships and the presence of significant variation between relative bacterial abundance and protein log2-fold change, we applied Spearman's correlation coefficient (*R*) using RStudio software.

Results {#S3}
=======

From the proteomic datasets, we identified 617 proteins in L, 613 proteins in CF, and 625 proteins in C2 ([Supplementary Tables S2](#TS2){ref-type="supplementary-material"}--[S4](#TS4){ref-type="supplementary-material"}, respectively). Accordingly, 608 proteins were common across all three treatment conditions ([Figure 2](#F2){ref-type="fig"}).

![Venn diagram depicting unique and shared proteins identified in the ileum of 10-day-old broilers treated *in ovo* with lactic acid bacteria mixture (L), *Citrobacter freundii* (CF), or *Citrobacter* spp. (C2).](fphys-11-00020-g002){#F2}

Subsequently, DEPs significantly lower or equal to 0.1 were identified. A total of 61 DEPs were displayed in L ([Table 1](#T1){ref-type="table"}), 44 DEPs in CF ([Table 2](#T2){ref-type="table"}), and 63 in C2 ([Table 3](#T3){ref-type="table"}). Furthermore, we only evaluated the biological interactions associated with inflammatory and immune response signaling.

###### 

Differentially expressed proteins (DEPs) from ileal samples of broilers treated with lactic acid bacteria mixture (L) *in ovo.*

  **UniProt ID**   **Proteins**   **Protein name**                                                       **Fold change**   ***p* Value**
  ---------------- -------------- ---------------------------------------------------------------------- ----------------- ---------------
  Q10751           ACE            Angiotensin I converting enzyme                                        --1.000           0.003
  P02612           MYL9           Myosin light chain 9                                                   2.400             0.004
  Q5ZIV5           PDCD10         Programmed cell death 10                                               6.800             0.005
  P20678           Cyp2c23        Cytochrome P450, family 2, subfamily c, polypeptide 23                 --10.000          0.007
  Q9PW72           PDLIM4         PDZ and LIM domain 4                                                   --2.000           0.013
  P24797           ATP1A2         ATPase Na + /K + transporting subunit alpha 2                          --1.600           0.014
  P50594           MAGOH          Mago homolog, exon junction complex subunit                            4.400             0.015
  Q90597           MX2            MX dynamin like GTPase 2                                               --1.600           0.016
  P08940           LECT2          Leukocyte cell derived chemotaxin 2                                    3.500             0.017
  P67883           RPL30          Ribosomal protein L30                                                  --1.660           0.019
  Q5ZMU6           PPP4R2         Protein phosphatase 4 regulatory subunit 2                             ∞                 0.021
  P31696-10        AGRN           Agrin                                                                  --5.000           0.024
  P02701           AVD            Avidin                                                                 6.700             0.027
  E1C2P3           HSPA14         Heat shock protein family A (Hsp70) member 14                          5.000             0.029
  P05180           Cyp2c23        Cytochrome P450, family 2, subfamily c, polypeptide 23                 --3.300           0.031
  P47990           XDH            Xanthine dehydrogenase                                                 --2.500           0.031
  Q5ZIW2           CNOT10         CCR4-NOT transcription complex subunit 10                              --3.300           0.032
  P05122-5         CKB            Creatine kinase B                                                      3.300             0.033
  P02789           TF             Transferrin                                                            --1.250           0.035
  O57535           NME2           NME/NM23 nucleoside diphosphate kinase 2                               --1.420           0.037
  Q6IVA4           UBA5           Ubiquitin like modifier activating enzyme 5                            3.500             0.038
  Q5ZKG5           ACP1           Acid phosphatase 1                                                     --2.000           0.041
  Q07598           SCP2           Sterol carrier protein 2                                               --2.000           0.042
  Q5ZKP6           ADA            Adenosine deaminase                                                    --2.000           0.043
  P09540           MYL4           Myosin light chain 4                                                   1.800             0.045
  Q5ZLN5           TARDBP         TAR DNA binding protein                                                --2.000           0.046
  P08636           RPS17          Ribosomal protein S17                                                  1.300             0.046
  P61160           ACTR2          ARP2 actin related protein 2 homolog                                   --1.250           0.051
  Q5ZJL9           SAMHD1         SAM and HD domain deoxynucleoside triphosphate triphosphohydrolase 1   2.600             0.052
  Q5ZK88           PSPC1          Paraspeckle component 1                                                --1.660           0.053
  Q90629           PRSS2          Serine protease 2                                                      --2.500           0.054
  Q02391           GLG1           Golgi glycoprotein 1                                                   --1.600           0.055
  P14105           MYH9           Myosin heavy chain 9                                                   --1.250           0.060
  P84173           PHB            Prohibitin                                                             --1.420           0.063
  P26990           ARF6           ADP ribosylation factor 6                                              2.400             0.063
  P47807           MYO1A          Myosin IA                                                              --1.600           0.066
  Q5ZLN1           PGAM1          Phosphoglycerate mutase 1                                              --1.420           0.068
  Q5ZHX7           CYB5R2         Cytochrome b5 reductase 2                                              --2.500           0.072
  Q5ZLR5           UQCRFS1        Ubiquinol-cytochrome c reductase, Rieske iron--sulfur polypeptide 1    1.400             0.074
  P17790           BSG            Basigin (Ok blood group)                                               2.100             0.075
  Q9YH06           HMGB1          High mobility group box 1                                              1.700             0.078
  Q5ZLT0           XPO7           exportin 7                                                             --2.000           0.084
  Q5ZKD7           MOV10          Mov10 RISC complex RNA helicase                                        --1.420           0.084
  P27003           S100A10        S100 calcium binding protein A10                                       ∞                 0.084
  P10184           SPINK5         Serine peptidase inhibitor, Kazal type 5                               --2.000           0.085
  P05083           ASL            Argininosuccinate lyase                                                2.200             0.085
  P23228           HMGCS1         3-Hydroxy-3-methylglutaryl-CoA synthase 1                              --2.500           0.086
  Q5ZM33           HP1BP3         Heterochromatin protein 1 binding protein 3                            1.500             0.086
  Q5ZK62           ACAP2          ArfGAP with coiled coil, ankyrin repeat PH domains 2                   --1.000           0.093
  P16924           P4HA1          Prolyl 4-hydroxylase subunit alpha 1                                   --1.420           0.095
  Q5ZKV8           KIF2A          Kinesin family member 2A                                               3.500             0.095
  O42265           PSMA1          Proteasome subunit alpha 1                                             --1.660           0.097
  P68139           ACTA1          Actin, alpha 1, skeletal muscle                                        3.200             0.098
  Q90615           ITGA1          Integrin subunit alpha 1                                               1.800             0.099
  Q5ZHP5           CHMP4B         Charged multivesicular body protein 4B                                 --1.420           0.100
  P70079           CKMT1          Creatine kinase U-type, mitochondrial                                  --1.250           0.100
  P09652           TUBB3          Tubulin beta 3 class III                                               2.500             0.100
  P24802           PLOD1          Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1                      3.000             0.100
  Q5ZKC1           EIF2A          Eukaryotic translation initiation factor 2A                            ∞                 0.100

###### 

Summary of differentially expressed proteins (DEPs) identified in the ileum of broilers exposed to *Citrobacter freundii* (CF) *in ovo.*

  **UniProt ID**   **Proteins**   **Protein name**                                                              **Fold change**   ***p* Value**
  ---------------- -------------- ----------------------------------------------------------------------------- ----------------- ---------------
  Q6JHU8           P3H1           Prolyl 3-hydroxylase 1                                                        3.200             0.003
  Q5ZKC9           YWHAZ          Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta   1.500             0.003
  Q5ZI89           TRAPPC11       Trafficking protein particle complex 11                                       --1.000           0.007
  Q01841           TGM2           Transglutaminase 2                                                            --1.420           0.010
  P00940           TPI1           Triosephosphate isomerase 1                                                   1.500             0.015
  Q10751           ACE            Angiotensin I converting enzyme                                               --10.000          0.016
  P55080           MFAP1          Microfibril-associated protein 1                                              7.500             0.018
  Q5ZIV5           PDCD10         Programmed cell death protein 10                                              5.800             0.021
  Q9PW72           PDLIM4         PDZ and LIM domain 4                                                          --5.000           0.021
  Q5ZM35           TWF2           Twinfilin actin binding protein 2                                             7.100             0.022
  Q90615           ITGA1          Integrin subunit alpha 1                                                      1.600             0.026
  Q02391           GLG1           Golgi glycoprotein 1                                                          --4.000           0.028
  Q5ZLN0           LRRC40         Leucine rich repeat containing 40                                             2.200             0.031
  Q5ZJ08           YARS           Tyrosyl-tRNA synthetase                                                       --4.000           0.031
  Q02020           FGB            Fibrinogen beta chain                                                         --1.600           0.032
  P26446           PARP1          Poly(ADP-ribose) polymerase 1                                                 --3.300           0.036
  Q9W6H0           OGN            Osteoglycin                                                                   1.600             0.037
  Q5ZKU5           RAB14          RAB14, member RAS oncogene family                                             --4.000           0.038
  P51890           LUM            Lumican                                                                       --2.500           0.042
  Q5ZHN4           RP2            RP2, ARL3 GTPase activating protein                                           --3.300           0.051
  P00548           PKM            Pyruvate kinase M1/2                                                          --1.250           0.052
  P0CB50           PRDX1          Peroxiredoxin 1                                                               --1.600           0.052
  P19966           TAGLN          Transgelin                                                                    2.100             0.057
  P87362           BLMH           Bleomycin hydrolase                                                           --2.500           0.059
  Q08392           Gsta1          Glutathione S-transferase alpha 1                                             1.700             0.059
  P13914           NAT1           *N*-acetyltransferase 1                                                       2.600             0.059
  Q5ZIY5           PPP2R2D        Protein phosphatase 2 regulatory subunit B delta                              2.000             0.062
  P05083           ASL            Argininosuccinate lyase                                                       2.200             0.064
  P23228           HMGCS1         3-Hydroxy-3-methylglutaryl-CoA synthase 1                                     --3.300           0.064
  Q90YH9           TES            Testin LIM domain protein                                                     --2.500           0.067
  Q5F381           EPCAM          Epithelial cell adhesion molecule                                             --1.420           0.069
  P56517           HDAC1          Histone deacetylase 1                                                         --4.000           0.070
  A0A1N8W591       HDAC1          Histone deacetylase                                                           1.200             0.075
  Q90611           MMP2           Matrix metallopeptidase 2                                                     --1.000           0.076
  Q5F418           PSMD1          Proteasome 26S subunit, non-ATPase 1                                          --4.000           0.076
  Q5ZIL2           VPS29          VPS29, retromer complex component                                             --1.000           0.076
  Q5F464           LPP            LIM domain containing preferred translocation partner in lipoma               1.300             0.079
  Q5ZJ27           HOOK1          Hook microtubule tethering protein 1                                          --1.000           0.090
  P02701           AVD            Avidin                                                                        6.200             0.099
  Q05744           CTSD           Cathepsin D                                                                   1.800             0.100
  P12902           HMG-14A        Non-histone chromosomal protein HMG-14A                                       --3.300           0.100
  Q98TF8           RPL22          Ribosomal protein L22                                                         2.000             0.100

###### 

Differentially expressed proteins (DEPs) in ileum of 10-day-old broilers exposed to *Citrobacter* spp. (C2) *in ovo.*

  **UniProt ID**   **Proteins**   **Protein name**                                                     **Fold change**   ***p* Value**
  ---------------- -------------- -------------------------------------------------------------------- ----------------- ---------------
  P05122           CKB            Creatine kinase B                                                    --1.250           0.002
  P47836           RPS4X          Ribosomal protein S4 X-linked                                        --1.600           0.002
  Q2IAL7           CATHL2         Cathelicidin-2                                                       4.500             0.003
  P05122-5         CPK-B          Creatine kinase B Isoform 4                                          --10.000          0.006
  P09652           TUBB3          Tubulin beta 3 class III                                             2.900             0.006
  Q9YGQ1           EEF1B2         Eukaryotic translation elongation factor 1 beta 2                    1.800             0.008
  Q5ZMU6           PPP4R2         Protein phosphatase 4 regulatory subunit 2                           ∞                 0.016
  P24802           PLOD1          Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1                    3.400             0.020
  Q5ZHP5           CHMP4B         Charged multivesicular body protein 4B                               --1.600           0.021
  Q5ZIW2           CNOT10         CCR4-NOT transcription complex subunit 10                            --5.000           0.028
  Q5ZKA4           EIF3J          Eukaryotic translation initiation factor 3 subunit J                 1.600             0.032
  Q90615           ITGA1          Integrin subunit alpha 1                                             1.600             0.032
  Q8UVD9           KHSRP          Far upstream element-binding protein 2                               --1.420           0.034
  P05083           ASL            Argininosuccinate lyase                                              2.300             0.035
  Q5ZHN4           RP2            RP2, ARL3 GTPase activating protein                                  --3.300           0.037
  Q5ZKC1           EIF2A          Eukaryotic translation initiation factor 2A                          ∞                 0.039
  P41125           RPL13          Ribosomal protein L13                                                1.700             0.041
  Q5ZLR5           UQCRFS1        Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1   1.600             0.044
  P27731           TTR            Transthyretin                                                        1.800             0.049
  Q5ZLN1           PGAM1          Phosphoglycerate mutase 1                                            --1.420           0.050
  P23228           HMGCS1         3-Hydroxy-3-methylglutaryl-CoA synthase 1                            --3.300           0.051
  P08106           HSPA2          Heat shock protein family A (Hsp70) member 2                         --1.420           0.051
  Q5ZK33           LETM1          Leucine zipper and EF-hand containing transmembrane protein 1        2.400             0.051
  P49712           ATP6V1B2       ATPase H + transporting V1 subunit B2                                1.600             0.052
  Q5ZJU3           ASNS           Asparagine synthetase (glutamine-hydrolyzing)                        1.700             0.053
  P24797           ATP1A2         ATPase Na + /K + transporting subunit alpha 2                        --1.420           0.053
  Q90629           PRSS2          Serine protease 2                                                    --2.500           0.053
  O73885           HSPA8          Heat shock protein family A (Hsp70) member 8                         --1.420           0.054
  P62846           RPS15          Ribosomal protein S15                                                2.000             0.060
  P26990           ARF6           ADP ribosylation factor 6                                            2.600             0.061
  Q90593           HSPA5          Heat shock protein family A (Hsp70) member 5                         --1.250           0.061
  P30622           CLIP1          CAP-Gly domain containing linker protein 1                           ∞                 0.062
  P09540           MYL4           Myosin light chain 4                                                 1.400             0.063
  O75083           WDR1           WD repeat domain 1                                                   3.000             0.063
  P10184           SPINK5         Serine peptidase inhibitor, Kazal type 5                             1.500             0.065
  O59725           mic60          MICOS complex subunit Mic60                                          8.000             0.066
  Q5ZL77           RIC8A          RIC8 guanine nucleotide exchange factor A                            ∞                 0.066
  P02675           FGB            Fibrinogen beta chain                                                1.800             0.068
  Q90835           EEF1A1         Eukaryotic translation elongation factor 1 alpha 1                   1.400             0.069
  Q5ZLD7           VPS53          VPS53, GARP complex subunit                                          ∞                 0.071
  P12276           FASN           Fatty acid synthase                                                  1.600             0.072
  E1C2P3           HSPA14         Heat shock protein family A (Hsp70) member 14                        3.200             0.072
  Q5ZJJ2           RPA1           Replication protein A1                                               --2.500           0.073
  P02314           HMGN2          Non-histone chromosomal protein HMG-17                               --2.500           0.075
  Q5ZLN0           LRRC40         Leucine rich repeat containing 40                                    2.000             0.076
  O93256           KRT19          keratin 19                                                           9.700             0.077
  Q9YHT2           SDHB           Succinate dehydrogenase complex iron sulfur subunit B                1.900             0.078
  P51890           LUM            Lumican                                                              --4.000           0.079
  Q5ZLL5           COQ5           Coenzyme Q5, methyltransferase                                       1.800             0.084
  P04354           CALB1          Calbindin 1                                                          --1.600           0.086
  Q5ZI72           HNRNPDL        Heterogeneous nuclear ribonucleoprotein D like                       1.800             0.086
  P02001           HBAD           Hemoglobin subunit alpha-D                                           1.800             0.088
  P08251           ATP1B1         ATPase Na+/K+transporting subunit beta 1                             --2.500           0.089
  P09102           P4HB           Prolyl 4-hydroxylase subunit beta                                    --1.250           0.090
  P12957           Cald1          Caldesmon 1                                                          --1.250           0.094
  P68139           ACTA1          Actin, alpha 1, skeletal muscle                                      3.200             0.096
  P02612           MYL9           Myosin light chain 9                                                 1.700             0.096
  P26583           HMGB2          High mobility group box 2                                            --2.500           0.097
  P08940           LECT2          Leukocyte cell derived chemotaxin 2                                  5.100             0.097
  Q5ZKQ5           CASC4          Cancer susceptibility 4                                              --1.600           0.100
  O13268           PSMA7          Proteasome subunit alpha 7                                           --1.420           0.100
  Q5ZHX1           RAP1B          RAP1B, member of RAS oncogene family                                 1.400             0.100
  P27003           S100A10        S100 calcium binding protein A10                                     ∞                 0.100

Biological Functions {#S3.SS1}
--------------------

To assess the functional annotation associated with DEPs, the disease processes and cellular functions were predicted by the IPA approach. [Figure 3](#F3){ref-type="fig"} summarizes the major predicted effects on functional annotation coordinated to the inflammatory and immune responses. In L treatment, inflammation of organ (*Z* score = 1.80) and inflammation of absolute region (*Z* score = 1.65) were predicted to be activated in relation to S control group ([Figure 3A](#F3){ref-type="fig"}). In CF, a predicted high activation *Z* score value was assigned only to inflammation of organ (*Z* score = 2.32). Biological functions associated with inflammatory response (*Z* score = −1.96), cell movement of granulocytes (*Z* score = −1.95) and leukocytes (*Z* score = −1.60) were predicted to be inhibited when compared to S control group ([Figure 3B](#F3){ref-type="fig"}). There was no qualified prediction of downstream functional effects in C2.

![Downstream effects analysis based on differentially expressed proteins from ileal samples of broilers early exposed to lactic acid bacteria mixture (L), *Citrobacter freundii* (CF), or *Citrobacter* spp. (C2). Biological functions involved with inflammation and immune response processes of (**A**) L vs. S, following (**B**) CF vs. S, (**C**) L vs. CF, and (**D**) L vs. C2. The vertical axis shows the predicted biological function, while the horizontal axis shows the *Z* score calculated for the particular effect.](fphys-11-00020-g003){#F3}

To better understand the differential regulation of inflammatory and immune signaling response across treatments, the L protein expression metadata generated by IPA were further compared to CF and C2 profiles (IPA comparison analyses). As illustrated in [Figure 3C](#F3){ref-type="fig"}, when L was compared to CF, the biological functional analysis predicted the activation of leukocyte migration (*Z* score = 1.54), immune response of leukocytes (*Z* score = 1.56), cellular infiltration by leukocytes (*Z* score = 1.64), cell movement of leukocytes (*Z* score = 1.67), cell movement of granulocytes (*Z* score = 2.19), and inflammatory response (*Z* score = 2.44). When examining L versus C2, there were predicted activation of inflammation of absolute anatomical region (*Z* score = 1.57), inflammation of organ (*Z* score = 1.62), and cell movement of neutrophils (*Z* score = 1.63; [Figure 3D](#F3){ref-type="fig"}).

Inflammatory-Related Proteins {#S3.SS2}
-----------------------------

Based on the IPA diseases and function annotation, the proteomic signatures associated with inflammatory downstream effects were identified ([Figure 4](#F4){ref-type="fig"} and [Supplementary Table S5](#TS5){ref-type="supplementary-material"}). Venn diagrams show the ileal DEPs related to inflammatory molecular functions ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}) in each *in ovo* treatment. The exposure to L *in ovo* downregulated the expression of eleven proteins (PRSS2, XDH, ADA, SCP2, SPINK5, ATP1A2, GLG1, PHB, MYH9, OVT, and ACE) and overexpressed eight (HMGB1, ITGA1, BSG, ARF6, MYL9, TUBB3, CKB, and LECT2). Similarly, there were nine downregulated (ACE, GLG1, HDAC1, PSMD1, PARP1, BLMH, PRDX1, TGM2, and PKM) and three upregulated DEPs (TPI1, ITGA1, and CTSD) found in CF versus S control. In the C2 treatment, the expression of eight proteins (CKB, ATP1B1, PRSS2, CALB1, CHMP4B, ATP1A2, HSPA8, and HSPA5) related to the inflammatory mechanism was downregulated. Likewise, seven DEPs (RAP1B, SPINK5, ATP6V1B2, SDHB, LECT2, TUBB3, MYL9, LETM1, ARF6, ITGA1, and EIF2A) were found to be upregulated in the ileum of C2-treated chicks. The Venn diagram showed that nine proteins (ATP1A2, TUBB3, LECT2, MYL9, PRSS2, CKB, ARF6, SPINK5, and CHMP4B) were present throughout L and C2 treatments, and only ITGA1 was shared across L, CF, and C2 ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). It is also important to note that some of the above proteins were implicated in more than one process.

![Differentially expressed proteins (DEPs) profiling identified by Ingenuity Pathway Analysis associated with the inflammatory annotation. **(A)** Heatmap plot represents the log2-fold changes of proteins expressed in ileal samples of broilers treated with lactic acid bacteria mixture (L), *Citrobacter freundii* (CF), or *Citrobacter* spp. (C2) in relation to control treatment. Orange shades represent underexpression, while blue shades indicate overexpression of the particular protein. Light gray cells indicate no expression. Hierarchical clustering in the rows is based on the protein composition similarity between treatments, while that in the columns is based on protein abundance.](fphys-11-00020-g004){#F4}

Causal Network {#S3.SS3}
--------------

Network analysis, derived from Ingenuity Knowledge Base, was drawn to determine the likely relevant causal relationships for changes in DEPs within the *in ovo* datasets. The top-enriched network in L treatment contained proteins associated with nucleic acid metabolism, skeletal and muscular development, and small molecule biochemistry (score, 44; 19 molecules, [Supplementary Figure S2A](#FS1){ref-type="supplementary-material"}). The DEPs identified in this network included ACP1, ACTA1, ACTR2, ADA, AGRN, ATP1A2, BSG, CKB, KIF2A, MX2, MYH9, MYL4, MYL9, P4HA1, PGAM1, RPS17, TARDBP, UBA5, and XDH.

Interestingly, only in the CF dataset, the top-enriched network was composed of several proteins related to immunological and inflammatory functions, as well as the hub regulators Hsp70, nuclear factor-κB (complex), Vegf, and CD3. This network complex was characterized as cancer, organismal injury, abnormalities, and respiratory disease (42 score, 17 molecules, [Figure 5](#F5){ref-type="fig"}), and the determined DEPs were CTSD, EPCAM, HDAC1, LPP, NAT1, OGN, PARP1, PKM, PRDX1, PSMD1, RAB14, RPL22, TES, TPI1, TWF2, YARS, and YWHAZ.

![The top-enriched IPA causal network in *Citrobacter freundii* (CF) relates to cancer, organismal injury, abnormalities, and respiratory disease. The networks are built graphically as nodes (gene/gene products) and edges (the biological relationship between nodes). The red nodes represent the upregulation of proteins in the dataset, while green represents downregulation. The color intensity represents the relative magnitude of change in protein expression.](fphys-11-00020-g005){#F5}

In C2, the most enriched network was linked to cellular function and maintenance, endocrine system disorders, and small molecule biochemistry (score 47, 20 molecules, [Supplementary Figure S2B](#FS1){ref-type="supplementary-material"}). This network consists of 20 proteins in our proteomic data set (ATP1A2, ATP1B1, ATP6V1B2, Cald1, CLIP1, HMGCS1, HSPA5, ITGA1, KRT19, LRRC40, LUM, MYL4, P4HB, PGAM1, PRSS2, RAP1B, RPS15, RPS4X, S100A10, and SDHB).

Correlation Analysis {#S3.SS4}
--------------------

Spearman's rank correlation was performed to search for potential positive relationships between the microbial composition and the intestinal inflammatory related-proteins ([Figure 6](#F6){ref-type="fig"} and [Supplementary Table S6](#TS6){ref-type="supplementary-material"}). Correlation analysis of the broilers' intestinal proteome and bacterial abundance revealed a positive relationship between *Candidatus Savagella*, also known as segmented filamentous bacteria (SFB), and myosin light chain 9 (MYL9; *R* = 0.95, *p* = 0.051) and Integrin alpha-1 (ITGA1; *R* = 0.95, *p* = 0.051). In addition, *Enterococcus* was positively associated with serine peptidase inhibitor Kazal type 5 (SPINK5; *R* = 0.95, *p* = 0.051).

![Spearman's rank correlation matrix of the dominant microbial populations and inflammation-related proteins in the ileum of 10-day-old broilers. Strong correlations are indicated by large circles. The colors of the scale bar denote the nature of the correlation, indicating a perfect positive correlation (dark blue) and --1 indicating perfect negative correlation (dark red). *Candidatus Savagella* population was positively correlated with MYL9 (*R* = 0.95, *p* = 0.051) and ITGA1 (*R* = 0.95, *p* = 0.051), as well as *Enterococcus* abundance had a positive association with SPINK5 (*R* = 0.95, *p* = 0.051).](fphys-11-00020-g006){#F6}

Discussion {#S4}
==========

Given the magnitude of understanding the cross-talk between intestinal microbiota and host physiology, the impact of the early intestinal colonization on the microbiota in young broilers has previously been addressed by our lab ([@B30]; [@B34]). To comprehensively complement these previous studies, we used a proteomic approach to examine the ileal protein composition in response to the early exposure to L-based probiotics or *Enterobacteriaceae* strains. The findings presented here indicate that the intestinal pioneer colonization may modulate the immunological functions of young broilers.

Predicted function analyses showed enhanced annotation related to inflammation signaling in broilers *in ovo* treated with L (*Z* score = 1.80; [Figure 3A](#F3){ref-type="fig"}) and CF (*Z* score = 2.32; [Figure 3B](#F3){ref-type="fig"}). The prediction of inflammatory signaling found in L treatment was supported by the upregulation of a marker of inflammation, such as high mobility group box 1 (HMGB1; [@B38]). Furthermore, treatment-specific biological functions found in L were associated with inflammatory response ([Figure 3C](#F3){ref-type="fig"}). In general, the inflammatory response may be beneficial for the host as an acute and transient mechanism to mediate clearance of inciting agents in the GIT. Alternatively, the failure to control inflammation could inflict chronic and severe tissue damage ([@B37]; [@B29]).

Currently, the predominant knowledge of intestinal inflammation in poultry is based on dysbiosis and mucosal barrier leakage studies ([@B23]; [@B3]; [@B10]). These physiological conditions are primarily caused by the proliferation and colonization of pathogens in the intestine. However, the recent multiomics pipelines have identified commensal bacteria not only influencing metabolic and immune function but also triggering a state of tolerance with an inflammation-like response ([@B4]; [@B19]). It has been proposed that SFB, a *Clostridiaceae* member, have a dominant effect on the mucosal immune system via stimulation of T cells, such as Th17, and increased proinflammatory cytokines and immunoglobulin A (IgA) production. Owing to the fact that colonization of SFB stimulates IgA release, it has been postulated as one of the mechanisms by which SFB might control pathogen overgrowth ([@B5]). On the other hand, the excessive immune reactions driven by SFB may also be accompanied by a physiological inflammation status ([@B15]; [@B16]; [@B6]; [@B4]). Our microbiome results previously published by [@B34] and [@B30] showed the succession of microbial communities colonization through the maturation of microbiota in chicks treated with L *in ovo*, with no evidence of potential pathogens overgrowth. Nonetheless, the previous findings showed a reduction in *Enterococcus* abundance and a particular prominent population of SFB in lower ileum of 10-day-old broilers in L treatment ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}; [@B30]). In this context, further action was taken to identify a potential microbial signature, which could be highly associated with the observed ileal inflammatory signaling. Spearman's coefficient analyses revealed a strong positive correlation between SFB population and ITGA1 and MYL9. The protein MYL9 plays a crucial role in the complex system that regulates the contraction of smooth muscle. Recently, [@B12] reported that MYL9 and MYL12 are functional ligands for CD69, suggesting that CD69-MYL9/12 interaction is also involved in recruiting activated cells to inflamed tissues. Indeed, high expression of MYL9/12 was related to sepsis-induced acute kidney injury, inflamed mouse airways, and patients with eosinophilic chronic rhinosinusitis ([@B36]; [@B12]). Similarly, [@B39] identified ITGA1 as an inflammatory-associated gene. Notably, we speculate that the high SFB population may be driving the predicted ileal mucosa proinflammatory status found in broilers early exposed to L. Nevertheless, the mechanism underlying SFB-mediated inflammation is yet unknown and must be further explored. Other groups have hypothesized that the interaction of commensal microbiota and young broilers during the development of the immune system could result in a transient inflammation without tissue damage. To the best of our knowledge, the link between SFB colonization and intestinal inflammation in broilers has not been proposed before. Future research is warranted to validate the SFB-associated proteomic signature generated from mass spectrometry. Such studies have the potential to develop markers of colonization and physiological effects mediated by SFB in human medicine and livestock.

Further support of early-life microbiota in programming immunological functions was shown by the biological annotation and causal network analyses. Treatment with L promoted a differential regulation of systemic immune processes in molecular profiles compared to CF and C2. The exposure of embryos to L enhanced the immune response function annotation associated with activation and trafficking of immune cells ([Figures 3C,D](#F3){ref-type="fig"}), and the top-enriched network was related to skeletal growth ([Supplementary Figure S2A](#FS1){ref-type="supplementary-material"}). *Citrobacter* treatments, particularly CF, promoted inhibition of functions linked to immune cell migration and inflammatory response ([Figures 3C,D](#F3){ref-type="fig"}, [5](#F5){ref-type="fig"}). Besides, based on the up- and downexpression pattern of proteins and the cause--effect relationships existing in Ingenuity Knowledge Base, a network related to injury and abnormalities in the organ was predicted in CF. This network is concerned primarily with the canonical nuclear factor-κB pathway, which is activated during the onset of inflammation ([@B24]). Our recent research has shown that the neonatal *Enterobacteriaceae* colonization mediated intestinal proteomic changes accompanied by inflammation in newly hatched chicks ([@B35]). Chronic inflammation develops when the immune system is unable to clear a persisting insult, which generates a harmful environment and results in tissue impair ([@B26]). Under all conditions, long-term inflammation can suppress immunity by decreasing immune cell numbers and function and/or increasing active immunosuppressive mechanisms ([@B8]). Based on the cumulative findings, it is thought that the introduction of CF *in ovo* produced specific host--microbe interactions, which may have led to dysregulated immunity and immunosuppression by inducing long-term inflammation in 10-day-old broilers.

The maturation of the immune system starts in the first week of life in broilers ([@B7]), and although the immune maturation process can be driven by genetics and environmental conditions, the intestinal microbial composition has been identified to play a significant role in modulating immune responses ([@B7]; [@B6]; [@B1]; [@B11]). Given these pieces of evidence, it is believed that manipulating the intestinal bacteria colonization with early-life exposure to L-based probiotics may modulate the development and maturation of immune functions of broilers. [@B25] and [@B28] have reported that the modification of early-life intestinal microbiota through *Lactobacillus*-based probiotics *in ovo* stimulated an immunomodulatory effect in broiler chickens. In addition, the supplementation of host-tailored probiotics has shown to enhance colonization of ileal SFB, which may have contributed to confer immunostimulatory benefits for turkeys ([@B33]). Our analyses here show that the high colonization of SFB ([@B30]) may be potentially associated with the enhancement of immune response in L-treated broilers at 10 days of age. These results increased the evidence that host-specific microbiota may drive the intestinal immune maturation ([@B15]; [@B7]; [@B6]; [@B4]; [@B13]).

In summary, the proteomics and bioinformatics analyses presented here suggest that despite shared predicted inflammation pathways by 10 days of age, triggers and inflammatory response were treatment specific in L and CF birds. Based on the microbiome profile previously published by [@B30], it is speculated that the high population of SFB in the ileum may be associated with the inflammation-like response found in L treatment, while the early intestinal colonization by *Enterobacteriaceae* may have caused a low-grade chronic inflammation in the intestine of CF birds. Supporting this, it was highlighted that proper immune function was dependent on specific intestinal microbiota. For instance, exposure of L-based probiotics may have shaped the development of immune functions, whereas the complexity of intestinal microbiota caused by early colonization of *Enterobacteriaceae* strains may have dysregulated the immunological response in 10-day-old broilers.
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